TORONTO, Feb. 4, 2021 /PRNewswire/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically incorporated cannabis frontrunner with core operations in Latin America and Europe, is very happy to announce that Alvaro Torres, Khiron CEO and manager, along side users for the Khiron administration group, will host a real time webcast on Wednesday, February 17 at 11:00am ET to talk about current outcomes and management’s perspective for 2021.
Management may also be hosting a 1×1 Virtual Roadshow with Harbor Access February 9-10, 2021 and playing the Benzinga Virtual Cannabis Capital Conference being held February 25-26, 2021. In addition, Mr. Torres are going to be playing the Benzinga Cannabis Hour on Thursday, February 11, 2021 as a panelist talking about the worldwide cannabis landscape.
Khiron Investor Day Webcast: 2021 Outlook
Date: Wednesday, February 17, 2021
Time: 11:00am-12:00pm ET
To register: https://event.on24.com/wcc/r/3002371/132B51F89A277D8D1AADD6CDB47FD509
Harbor Access 1×1 Virtual Roadshow
Date: February 9-10, 2021
To register: Email [email protected] to book 1×1 meeting
Benzinga Cannabis Hour: Overseas Cannabis
Date: Thursday, February 11 at 4pm ET
To attend: http*)Benzinga that is://bzcannabishour.com Virtual Cannabis Capital Conference
Date: February 25-26, 2021 at 1:30pm ET
To register: https://events.benzinga.com/squeeze-page-422415971607984646162
Recent Company Highlights
- In 2020, achieves 50% compound monthly growth rate (CMGR) in medical cannabis prescriptions (April to December), reaching 7,500 paid prescriptions as of January 31, 2021
- Colombian government extends medical health insurance coverage to THC and CBD medical cannabis products, resulting in strong month-over-month growth in December 2020 and January 2021
- On December 9th, Khiron opens new small-format clinic in Medellin, Colombia’s 2nd city that is largest, included in the Company’s want to expand its medical cannabis clinics across Colombia and Latin America.
- Company appoints previous Colombia Minister of Finance Juan Carlos Echeverry as an unbiased person in its Board of Directors
- Khiron declared a National Strategic venture by the federal government of Colombia, which simplifies and accelerates management procedures for the Company’s strategic initiatives
- Khiron may be the very first cannabis business in Colombia to deliver THC services and products internationally
About Khiron Life Sciences Corp.
Khiron is a vertically built-in medical and CPG cannabis business with core operations in Latin America, and activity that is operational Europe and North America. Khiron is the leading medical cannabis provider in Colombia and the first company licensed in Colombia for the cultivation, production, domestic distribution and sales, and international export of both low and high THC medical cannabis products. The Company has filled medical cannabis prescriptions in Colombia, Peru and the UK, and is positioned to commence sales of medical cannabis in Germany and Brazil in early 2021.
Leveraging wholly-owned medical clinics and telemedicine that is proprietary, Khiron combines a patient-oriented approach, doctor training programs, systematic expertise, item innovation, and agricultural infrastructure to push prescriptions and brand name commitment. Its health device established the initial CBD that is branded skincare in Colombia, with KuidaTM now marketed in multiple jurisdictions in Latin America, the US and UK. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and executive that is diverse and Board of Directors.
Visit Khiron online at investors.khiron.ca as well as on Instagram @khironlife.
This news release may include certain information that is“forward-looking and “forward-looking statements” within the meaning of applicable securities legislation. All information contained herein that is not historical in nature may constitute information that is forward-looking. Khiron undertakes no responsibility to touch upon analyses, objectives or statements created by third-parties in respect of Khiron, its securities, or monetary or working outcomes (as relevant). Although Khiron thinks that the objectives reflected in forward-looking statements in this news release are reasonable, such statement that is forward-looking been based on expectations, factors and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond Khiron’s control, including the risk factors discussed in Khiron’s Annual Information Form which is available on Khiron’s SEDAR profile at www.sedar.com. The information that is forward-looking in this news release is expressly qualified by this cautionary declaration and it is made at the time of the date hereof. Khiron disclaims any intention and it has no responsibility or obligation, except as needed for legal reasons, to upgrade or revise any information that is forward-looking whether as a result of new information, future events or otherwise.
Neither The TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the accuracy or adequacy of this news release.
Get Real-Time Updates from MJobserver.com